Contract sales & marketing

IQVIA’s One Home for Sites: Reducing tech overload in clinical research

25-Jul-2024 By Liza Laws

IQVIA's One Home for Sites addresses the growing complexity in clinical research by consolidating various software applications and portals into a single, easy-to-use platform.

AI, patient engagement, and interoperability: Innovations shaping clinical trials

24-Jul-2024 By Liza Laws

As clinical trials continue to evolve, next-generation mobile technologies and applications are at the forefront of transforming the research landscape.

FDA approves Rusan Pharma’s manufacturing facility in India, paving the way for expanded US presence

23-Jul-2024 By Liza Laws

Rusan Pharma Private Limited has announced that its active pharmaceutical ingredient (API) manufacturing facility in Ankleshwar, Gujarat, has been granted Good Manufacturing Practice (GMP) approval by the FDA.

Phathom Pharmaceuticals receives FDA approval for Voquezna to treat non-erosive GERD

19-Jul-2024 By Liza Laws

Phathom Pharmaceuticals, Inc.dedicated to developing and commercializing treatments for gastrointestinal (GI) diseases, announced today that the US Food and Drug Administration (FDA) has approved Voquezna (vonoprazan) 10mg tablets for the relief of heartburn...

Avista and Hamilton Lane join forces to Propel growth and innovation at Cosette Pharmaceuticals

19-Jul-2024 By Liza Laws

Avista, a New York-based private equity firm focused on healthcare, and Hamilton Lane, a global private markets investment management firm, have announced that funds managed by Hamilton Lane have acquired a significant equity interest in Cosette Pharmaceuticals...

Top 5 CDMOs driving advanced therapies to market amid rising demand and challenges

18-Jul-2024 By Jonathan Smith

Contract development and manufacturing organizations (CDMOs) perform vital services for the biopharmaceutical industry – a role that is growing as cell and gene therapies gain momentum. Here are five of the top CDMOs bringing advanced therapies toward...

CordenPharma invests €900M in expanding peptide platform to meet GLP-1 drug demand

18-Jul-2024 By Clara Rodriguez Fernandez

CordenPharma, a US-based contract development and manufacturing organization (CDMO), will be making a €900 million investment over the next three years into expanding its peptide technology platform at its US and Europe sites.

Nipro's $397.8M investment brings 232 new jobs to Greenville, NC with exciting new facility

18-Jul-2024 By Liza Laws

Japanese medical devices company, Nipro Medical Corporation, a giant in the healthcare and medical device industry, has announced a major investment of $397.8 million to establish its first North American manufacturing center of excellence in Greenville,...

DIA 2024

Discover how Marwan Fathallah is transforming DIA and hoping to revolutionize global healthcare

18-Jul-2024 By Liza Laws

At the DIA 60th annual conference in San Diego, senior editor Liza Laws from Outsourcing Pharma had the opportunity to sit down with Marwan Fathallah, President and CEO of DIA.

Caroline Shleifer on founding RegASK and her journey in science and regulatory affairs

18-Jul-2024 By Liza Laws

Caroline Shleifer is the founder and CEO of RegASK, the global, AI-driven solution for curated regulatory intelligence.

JOGO Health and Mayo Clinic announce partnership to change understanding and treatment of tremors

17-Jul-2024 By Liza Laws

JOGO Health, a leader in non-invasive digital therapeutics, has announced a pivotal collaboration with the Mayo Clinic to study tremors.

How are pharmacists changing liver health management and prevention strategies?

16-Jul-2024 By Liza Laws

Dr. Catherine Duggan, chief executive officer of the International Pharmaceutical Federation (FIP), has been at the helm since June 2018, based in The Hague.

Celadon Pharmaceuticals celebrates eighth harvest, poised for 15 a year

16-Jul-2024 By Liza Laws

Today (July 16) Celadon Pharmaceuticals Plc, a trailblazer in the UK’s pharmaceutical industry, has achieved a significant milestone with the successful completion of its eighth cannabis harvest of 2024.

OMNY Health uses real-world data to enhance patient outcomes and drive positive change

16-Jul-2024 By Liza Laws

OMNY Health is changing the healthcare industry by connecting providers and life sciences companies through a comprehensive data ecosystem.

Thermo Fisher's new EU ultra-cold facility to boost advanced therapies development

12-Jul-2024 By Liza Laws

Thermo Fisher’s cutting-edge ultra-cold facility in Bleiswijk, Netherlands, aims to accelerate advanced therapies development by offering comprehensive cold and ultra-cold services.

Overcoming barriers to opioid treatment: Challenges and innovations in methadone and buprenorphine

10-Jul-2024 By Liza Laws

The growing opioid crisis in the US has been exacerbated by various systems and biases, preventing individuals from accessing critical treatments like methadone and buprenorphine.

Advancing sleep health: Wearable technologies revolutionize clinical trials and patient care

02-Jul-2024 By Liza Laws

Christine Guo, chief scientific officer at ActiGraph, discusses the pivotal role of wearable health technologies in revolutionizing sleep health measurement within clinical trials.

Revolutionary AI tech by Leal Health offers new hope for cancer patients - learn how

27-Jun-2024 By Liza Laws

In this exclusive Q&A, Liza Laws sits down with Leal Health to discuss their groundbreaking GenAI single point of access technology.

Novo Nordisk announces $4.1BN investment to expand US manufacturing capacity

25-Jun-2024 By Liza Laws

Yesterday (June 24) Novo Nordisk unveiled plans to invest $4.1 billion (approximately €3.8 billion) in a new manufacturing facility in Clayton, North Carolina.

IQVIA's participant payments: Streamlining clinical trial payments for global compliance

18-Jun-2024 By Liza Laws

OSP recently had the opportunity to sit down with Jim DiCesare, senior director of Americas operations at IQVIA, to discuss their innovative participant payments service.

EQT invests in CluePoints to boost AI-driven clinical trial data quality and compliance

13-Jun-2024 By Liza Laws

CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, has secured significant investment from EQT for its continued growth.

EMA consolidates guidelines for computerized systems in clinical trials

13-Jun-2024 By Liza Laws

To guide sponsors, investigators, CROs, and other parties in clinical research, the European Medicines Agency (EMA) has consolidated the contemporary requirements for using computerized systems and electronic data in clinical trials.

New AI-powered tool streamlines trial feasibility and re-forecasting from start to finish

11-Jun-2024 By Liza Laws

Lokavant, a leader in clinical trial intelligence, has just launched Spectrum, a cutting-edge AI software designed to revolutionize clinical trial feasibility and optimization.

Systech unveils game-changing turnkey solution for pharma rework and aggregation

10-Jun-2024 By Liza Laws

In a groundbreaking development, Systech, a subsidiary of Markem-Imaje and Dover, has introduced a turnkey manual aggregation and rework solution tailored for pharmaceutical manufacturers, CMOs, CDMOs, re-packagers, and wholesalers.

Does Stardog AI hold the key to faster pharma success?

06-Jun-2024 By Liza Laws

In today's fast-paced pharmaceutical industry, major players are seeking innovative solutions to accelerate the drug development process.

Roquette's US innovation center marks first year of pharmaceutical advancements

06-Jun-2024 By Liza Laws

As Roquette's US Innovation Center marks its first anniversary, Roquette took the opportunity to reflect on its interesting journey and achievements over the past year.

Secrets to trial success: CluePoints reveals how its tech is transforming research

05-Jun-2024 By Liza Laws

As the DIA conference in San Diego approaches, Outsourcing Pharma secured an exclusive preview with François Torche, chief product & technology officer and co-founder of CluePoints

Advarra survey - use of sponosr tech greatest burden faced by sites

05-Jun-2024 By Liza Laws

As DIA's 60th anniversary at the annual event in San Diego approaches, OSP is excited to bring you insights from Advarra, a leader in advancing clinical research.

DIA 2024

AI at DIA 2024: GiftHealth unveils game-changing patient support innovations

05-Jun-2024 By Liza Laws

Get ready for a big reveal at the DIA conference in San Diego as GiftHealth introduces its latest AI-enabled features designed to revolutionize patient care.

DIA 2024

Discover how Phastar is making a vast contribution the life sciences community at DIA 2024

05-Jun-2024 By Liza Laws

At the DIA 2024 Global Annual Meeting, Phastar iwill be proud to join a diverse group of stakeholders from industry, regulatory bodies, academia, and patient communities.

Transforming clinical trials: Medable and Masimo's game-changing partnership unveiled

03-Jun-2024 By Liza Laws

In a collaboration set to alter the landscape of clinical trials, Medable Inc. and Masimo have announced a strategic partnership aimed at revolutionizing evidence generation in medical research.

Asahi Kasei's $1.1 billion power move - acquiring Calliditas to dominate global healthcare

30-May-2024 By Liza Laws

In a bold move set to reshape the global healthcare landscape, Asahi Kasei Corp. announced its intent to acquire Swedish drug maker Calliditas Therapeutics AB through a voluntary tender offer.

Orla Cussen tells all women in science to seek out role models and let nothing stop you

29-May-2024 By Liza Laws

Orla Cussen is associate director- engagement delivery lead, Cork, Life Sciences Manufacturing at Cognizant.

Novigenix collaborates with IMMUcan Consortium using AI platform to fight cancer

13-May-2024 By Liza Laws

Novigenix, a force in innovative cancer diagnostics, has announced a landmark partnership with the IMMUcan Consortium, a European leader in cancer research.

Walgreens to be used as clinical trial sites focusing on obesity and type 2 diabetes

07-May-2024 By Liza Laws

Walgreens and Boehringer Ingelheim have joined forces in a move to enhance diversity and accessibility in clinical trials, aiming to make participation more inclusive and equitable.

Unlocking Synergies: LGM Pharma's strategic approach to sourcing and growth in India

26-Apr-2024 By Liza Laws

In an extensive and enlightening chat with Prasad Raje, the CEO of LGM Pharma, OSP gained profound insights into the company's trajectory within the pharmaceutical industry.

WuXi AppTec denies client data sharing allegations and defends industry integrity

25-Apr-2024 By Liza Laws

Wuxi AppTec says recent allegations made by the US government that it has shared clients' data with Beijing without consent are ‘misleading’ and ‘inaccurate’.

CPHI 2024

One2Treat - observing emerging trends and reshaping approaches to R&D

25-Apr-2024 By Liza Laws

Last month, OSP was excited to write about One2Treat, a progressive startup specializing in digital health solutions, which has launched a forward-thinking approach aimed at tackling key challenges in the biopharma industry.

Karen Ooms' keen interest in Schrodinger's Cat and how it led to a 35-year career in science

24-Apr-2024 By Liza Laws

From a child's chemistry set given to her by her grandfather to watching Open University maths programs, Karen Ooms seemed destined for a career in science.

Made in the USA: Ultrahuman to become first facility dedicated to producing wearable rings

23-Apr-2024 By Liza Laws

Ultrahuman, a force in wearable technology, has boldly planted its flag on American soil with the inauguration of UltraFactory.

Vivalink and RSRT collaborate to improve Rett syndrome research with wearable technology

23-Apr-2024 By Liza Laws

In a major partnership aimed at accelerating research into Rett syndrome, a rare neurological disorder predominantly affecting girls, digital healthcare solutions company Vivalink, has joined forces with the Rett Syndrome Research Trust (RSRT).

Catching up with LGM Pharma ahead of CPhI North America to find out about its pipeline

19-Apr-2024 By Liza Laws

LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical, biotechnology, and compounding pharmacy industries.

New IQVIA research reveals growing trend as pharma embraces combined PV solutions

17-Apr-2024 By Liza Laws

Archana Hegde joined IQVIA in 2015 and has been in various leadership roles implementing technology solutions to support critical business processes.

Production of tree-saving transformative vaccine adjuvant with in-lab plants

17-Apr-2024 By Liza Laws

During DCAT this year, CEO Gaston Salinas from Botanical Solution Inc., (BSI), sat down with Liza Laws, the senior editor of OSP and BPR to discuss his company’s pioneering work in revolutionizing vaccine adjuvant production.

FDA greenlights Prenosis' AI solution for sepsis diagnosis: is this a paradigm shift in healthcare?

09-Apr-2024 By Liza Laws

In a landmark development poised to reshape the landscape of medical diagnostics, the US Food and Drug Administration (FDA) has officially sanctioned Prenosis' pioneering artificial intelligence (AI) tool designed for the early detection of sepsis.

Vox Pop Pharma – the industry speaks out about advanced AI and biophysical modeling

04-Apr-2024 By Liza Laws

In an overwhelming response to the news that SimBioSys and General Inception had joined forces to use advanced AI and biophysical modeling, to gain deeper insights into tumor biology, the industry has spoken.

Bora Pharmaceuticals completes Upsher-Smith acquisition, expanding North American footprint

02-Apr-2024 By Liza Laws

Bora Pharmaceuticals Co., Ltd. yesterday (April 1) finalized the acquisition of Upsher-Smith Laboratories, Inc., a leading generics manufacturer based in Minnesota, U.S., from its previous owners, Sawai Group Holdings and Sumitomo Corporation of Americas.

The crucial tool in Anju's arsenal and how being patient focused is becoming a cliche

28-Mar-2024 By Liza Laws

Being patient focused is becoming a cliche and actions speak louder than words Anju's Larry Birch claimed during SCOPE 2024.

SCOPE 2024

Slope: why are traditional approaches to sample tracking and data management no longer sufficient?

07-Mar-2024 By Liza Laws

Mark Melton is a precision-based medicine and biospecimen operations expert at Slope.

Two new purpose-built facilities built for Almac Group in Northern Ireland to meet growing demand

06-Mar-2024 By Liza Laws

Almac Group, a global leader in CDMOs, announced today (March 6) that it has unveiled two new purpose-built facilities at its headquarters in Northern Ireland.